{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T18:17:31Z","timestamp":1787163451414,"version":"build-2736575974"},"reference-count":18,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.jpba.2025.117328","type":"journal-article","created":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T19:13:19Z","timestamp":1767208399000},"page":"117328","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Separation of mephentermine from other structural analogues of phenethylamine and amphetamine in biological matrices using Liquid Chromatography-Tandem Mass Spectrometry"],"prefix":"10.1016","volume":"271","author":[{"given":"Tusha","family":"Tripathi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamna","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Awanish","family":"Upadhyay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashok","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Puran Lal","family":"Sahu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarun","family":"Handa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meghna","family":"Choudhary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bikash","family":"Medhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpba.2025.117328_bib1","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.ccc.2021.03.002","article-title":"Drugs of abuse: sympathomimetics","author":"Brown","year":"2021","journal-title":"Crit. Care Clin. 37"},{"key":"10.1016\/j.jpba.2025.117328_bib2","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.nic.2023.07.003","article-title":"Imaging of drug-related vasculopathy","author":"Puac-Polanco","year":"2024","journal-title":"Neuroimaging Clin. N. Am. 34"},{"key":"10.1016\/j.jpba.2025.117328_bib3","first-page":"1793","article-title":"Natural Sympathomimetic Drugs: from Pharmacology to Toxicology","volume":"12","author":"Costa","year":"2022","journal-title":"Biomol"},{"key":"10.1016\/j.jpba.2025.117328_bib4","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.jpba.2017.11.024","article-title":"Rapid and simple procedure for the determination of cathinones, amphetamine-like stimulants and other new psychoactive substances in blood and urine by GC\u2013MS","volume":"149","author":"Mercieca","year":"2018","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2025.117328_bib7","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jchromb.2019.04.052","article-title":"Determination of amphetamine-type stimulants in urine samples using microextraction by packed sorbent and gas chromatography-mass spectrometry","volume":"1120","author":"Malaca","year":"2019","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.jpba.2025.117328_bib8","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.jpba.2017.09.020","article-title":"Application of gas chromatography\u2013tandem mass spectrometry for the determination of amphetamine-type stimulants in blood and urine","author":"Wo\u017aniak","year":"2018","journal-title":"J. Pharm. Biomed. Anal. 148"},{"key":"10.1016\/j.jpba.2025.117328_bib9","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1039\/C8AY00041G","article-title":"Determination of amphetamine-type stimulants (ATSs) and synthetic cathinones in urine using solid phase micro-extraction fibre tips and gas chromatography-mass spectrometry","volume":"10","author":"Alsenedi","year":"2018","journal-title":"Anal. Methods"},{"key":"10.1016\/j.jpba.2025.117328_bib10","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jpba.2017.12.025","article-title":"High resolution full scan liquid chromatography mass spectrometry comprehensive screening in sports antidoping urine analysis","author":"Abushareeda","year":"2018","journal-title":"J. Pharm. Biomed. Anal. 151"},{"key":"10.1016\/j.jpba.2025.117328_bib11","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jchromb.2016.06.045","article-title":"Determination of phentermine, N-hydroxyphentermine and mephentermine in urine using dilute and shoot liquid chromatography\u2013tandem mass spectrometry","volume":"1029-1030","author":"Choi","year":"2016","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.jpba.2025.117328_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2021.114317","article-title":"Enantioselective determination of plasma protein binding of common amphetamine-type stimulants","volume":"205","author":"Losacker","year":"2021","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2025.117328_bib13","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1093\/jat\/34.2.73","article-title":"Confirming urinary excretion of mephentermine and phentermine following the ingestion of oxethazaine by gas chromatography-mass spectrometry analysis","volume":"34","author":"Huang","year":"2010","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.jpba.2025.117328_bib14","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1248\/bpb.b17-00118","article-title":"Inhibitory effects of gastrointestinal drugs on CYP activities in human liver microsomes","volume":"40","author":"Iwase","year":"2017","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.jpba.2025.117328_bib15","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1111\/jphp.12703","article-title":"Complexation of oxethazaine with 2-hydroxypropyl-\u03b2-cyclodextrin: increased drug solubility, decreased cytotoxicity and analgesia at inflamed tissues","volume":"69","author":"Prado","year":"2017","journal-title":"J. Pharm. Pharm."},{"key":"10.1016\/j.jpba.2025.117328_bib16","unstructured":"G. Sigmund, I. Seinsch, W. Sch\u00e4nzer, Detection of Phentermine and Phentermine Derivatives as Metabolites of Oxethazine, In: {C}{C}W. Sch\u00e4nzer, H. Geyer, A. Gotzmann, U. Mareck- Engelke{C}{C} (eds). Recent Advances in doping analysis, Sport und Buch Strau\u00df, K\u00f6ln, 6, 1999, pp. 483- 487."},{"key":"10.1016\/j.jpba.2025.117328_bib18","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.forsciint.2008.12.009","article-title":"Oxethazaine as the source of mephentermine and phentermine in athlete's urine","volume":"185","author":"Hsu","year":"2009","journal-title":"Forensic Sci. Int"},{"key":"10.1016\/j.jpba.2025.117328_bib19","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.pbb.2013.01.022","article-title":"The abuse potential of oxethazaine: effects of oxethazaine on drug-seeking behavior and analysis of its metabolites in plasma and hair in animal models","volume":"105","author":"Lee","year":"2013","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.jpba.2025.117328_bib22","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.chroma.2019.04.050","article-title":"Development and validation of a semi-quantitative ultra-high performance liquid chromatography-tandem mass spectrometry method for screening of selective androgen receptor modulators in urine","volume":"1600","author":"Ventura","year":"2019","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.jpba.2025.117328_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jchromb.2016.11.008","article-title":"Validated quantification method for five ephedrines in dietary supplements using LC\u2013MS\/MS: application to 503 cases","volume":"1039","author":"Zhang","year":"2016","journal-title":"J. Chromatogr. B"}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708525006697?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708525006697?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T14:34:29Z","timestamp":1773930869000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708525006697"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":18,"alternative-id":["S0731708525006697"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2025.117328","relation":{},"ISSN":["0731-7085"],"issn-type":[{"value":"0731-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Separation of mephentermine from other structural analogues of phenethylamine and amphetamine in biological matrices using Liquid Chromatography-Tandem Mass Spectrometry","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2025.117328","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117328"}}